Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

Federico Cappuzzo,Antonio Marchetti,Margaret Skokan,Elisa Rossi,Sujatha Gajapathy,Lara Felicioni,Maela Del Grammastro,Maria Grazia Sciarrotta,F Buttitta,Matteo Incarbone,Luca Toschi,Giovanna Finocchiaro,Annarita Destro,Luigi Terracciano,Massimo Roncalli,Marco Alloisio,Armando Santoro,Marileila Varella-Garcia

Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

2009

Federico Cappuzzo
Antonio Marchetti
Margaret Skokan
Elisa Rossi
Sujatha Gajapathy
Lara Felicioni
Maela Del Grammastro
Maria Grazia Sciarrotta
F Buttitta
Matteo Incarbone
Luca Toschi
Giovanna Finocchiaro
Annarita Destro
Luigi Terracciano
Massimo Roncalli
Marco Alloisio
Armando Santoro
Marileila Varella-Garcia

Purpose To investigate the prognostic role of genomic gain for MET and epidermal growth factor receptor (EGFR) genes in surgically resected non‐small-cell lung cancer (NSCLC).

Keywords:

Respiratory disease
Onartuzumab
Epidermal growth factor receptor
Cell
Gene dosage
Cancer
Pathology
Copy-number variation
Lung cancer
Medicine
Gene
Retrospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

443

Citations